---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-151224"
form_type: "8-K"
ticker: "BCLI"
cik: "0001137883"
company_name: "BRAINSTORM CELL THERAPEUTICS INC."
filed_at: "2021-12-17T23:59:59+00:00"
generated_at: "2026-06-28T00:01:17.484841+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Abbhi retires; shareholders elect board, approve say-on-pay and auditor

## Summary
- Sankesh Abbhi retired from Board effective Dec. 14, 2021, prior to Annual Meeting; no disagreement.
- All seven director nominees (Arbel, Almenoff, Polverino, Frenkel, Taub, Yablonka, Bairu) elected.
- Non-binding advisory vote on executive compensation passed: 7,594,234 for, 981,374 against.
- Ratification of Brightman Almagor Zohar & Co. as auditor approved: 19,042,561 for.

## SEC filing metadata
- accession: 0001104659-21-151224
- form_type: 8-K
- ticker: BCLI
- cik: 0001137883
- company_name: BRAINSTORM CELL THERAPEUTICS INC.
- filed_at: 2021-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1137883/000110465921151224/0001104659-21-151224-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1137883/000110465921151224/tm2135639d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-151224
- JSON: https://secwatch.observer/filing/0001104659-21-151224.json
- Plain text: https://secwatch.observer/filing/0001104659-21-151224.txt

## Key facts
- Executive change
  Sankesh Abbhi retired as Director at BRAINSTORM CELL THERAPEUTICS INC..
  - Action: retired
  - Role: Director
  source text: On December 14, 2021, Sankesh Abbhi retired from the Board of Directors (the “Board”) of Brainstorm Cell Therapeutics Inc. (the “Company”), effective immediately prior to the commencement of the 2021 Annual Meeting of Stockholders (the “Annual Meeting”) of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1137883/000110465921151224/0001104659-21-151224-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.